SCHEMBL24310675

SCHEMBL24310675

Cc1c(Cl)nc(NS(=O)(=O)c2cnn(C)c2)nc1Oc1cccc(N2CCN(C)CC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.43
▸ HTR2A P28223 1/20 0.43
▸ HTR2C P28335 1/20 0.43
▸ HTR7 P34969 1/20 0.43
▸ DRD3 P35462 1/20 0.43
▸ HTR6 P50406 1/20 0.43
▸ EGFR P00533 14/20 0.41
▸ GUSB P08236 1/20 0.41
▸ CTSC P53634 3/20 0.41
▸ NUAK1 O60285 2/20 0.40
▸ NUAK2 Q9H093 2/20 0.40
▸ JAK2 O60674 2/20 0.40
▸ BLK P51451 2/20 0.40
▸ BMX P51813 2/20 0.40
▸ JAK3 P52333 2/20 0.40
▸ RAD52 P43351 2/20 0.39
▸ PLK4 O00444 1/20 0.38
▸ GAK O14976 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ PTK2 Q05397 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309808 0.88 CTSC (0.46) HTR1AHTR2AHTR2CHTR7DRD3
SCHEMBL29566696 0.88 CTSC (0.46) HTR1AHTR2AHTR2CHTR7DRD3
SCHEMBL24309381 0.86 HTR7 (0.42) HTR1AHTR2AHTR2CHTR7DRD3
SCHEMBL29567219 0.86 HTR7 (0.42) HTR1AHTR2AHTR2CHTR7DRD3
SCHEMBL29567464 0.85 HTR1A (0.41) HTR1AHTR2AHTR2CHTR7DRD3
SCHEMBL26808930 0.85 HTR1A (0.41) HTR1AHTR2AHTR2CHTR7DRD3
SCHEMBL24310431 0.81 HTR2C (0.41) HTR1AHTR2AHTR2CHTR7DRD3
SCHEMBL29566298 0.81 HTR2C (0.41) HTR1AHTR2AHTR2CHTR7DRD3
SCHEMBL26808712 0.81 HTR7 (0.41) HTR1AHTR2AHTR2CHTR7DRD3
SCHEMBL26811481 0.81 HTR2C (0.40) HTR1AHTR2AHTR2CHTR7DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback